Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4M Buy
59,754
+56,155
+1,560% +$11.5M 0.07% 161
2025
Q4
$922K Buy
+3,599
New +$944K 0.01% 422
2025
Q3
Sell
-305,720
Closed -$74.7M 921
2025
Q2
$74.7M Buy
+305,720
New +$76.2M 0.65% 35
2025
Q1
Sell
-6,003
Closed -$1.52M 760
2024
Q4
$1.52M Sell
6,003
-57,280
-91% -$15.4M 0.03% 187
2024
Q3
$20M Sell
63,283
-85,835
-58% -$30.6M 0.46% 51
2024
Q2
$55.7M Buy
149,118
+21,290
+17% +$7.19M 1.5% 14
2024
Q1
$44.3M Buy
127,828
+50,661
+66% +$19.2M 1.44% 18
2023
Q4
$35.3M Buy
+77,167
New +$38M 1.39% 11
2023
Q3
Sell
-18,000
Closed -$8.05M 239
2023
Q2
$8.05M Sell
18,000
-5,000
-22% -$2.52M 1.45% 17
2023
Q1
$11.2M Buy
+23,000
New +$11.4M 1.48% 16

Other funds holding HUM

Marex Group's HUM Position: Q1 2026 in Review

Marex Group increased its Humana (HUM) stake by 1,560% in Q1 2026, buying an estimated $11.5M and bringing the position to 59,754 shares worth $10.4M. The position accounts for 0.07% of the portfolio, ranked #161.

Marex Group first reported a position in HUM in Q1 2023 and has held it in 10 quarters since. The position peaked at $74.7M in Q2 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Marex Group held 59,754 shares of Humana worth $10.4M as of Q1 2026.
  • Marex Group bought 56,155 Humana shares in Q1 2026, an estimated $11.5M.
  • Humana made up 0.07% of Marex Group's portfolio in Q1 2026, its #161 holding.
  • Marex Group first reported a position in Humana in Q1 2023 and has held it in 10 quarters since.
  • Marex Group's Humana position peaked at $74.7M in Q2 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.